BRIDGEWATER, N.J., June 25, 2021 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (SNCR) (the “Company” or “Synchronoss”), a global leader and innovator in cloud, messaging and digital products and platforms, today announced the pricing of an underwritten public offering of 38,461,538 shares of its common stock at a public offering price
REGULATED INFORMATION INSIDE INFORMATION Nyxoah Announces Launch of Proposed Public Offering in the United States Mont-Saint-Guibert, Belgium – June 25, 2021, 12:30 pm CET / 6:30 am ET – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep […]
-The Vietnamese economy has fared better than most during the COVID-19 pandemic and is well placed to capture renewed FDI interest, according to an article posted on the UK website lexology.com. The article said after joining the World Trade Organization in 2007 and many regional conventional trade agreements with many significant economies, Vietnam has become
-Prime Minister Pham Minh Chinh has requested accelerating the transfer of vaccine production technology and the development of home-grown COVID-19 vaccines so that Vietnam will be able to produce the vaccines no later than June next year. He made the order while working with several producers of vaccines, biological
Tran Anh Khoa, playing Rom in the movie of the same name, took home the Best Actor Award at the 18th Asian Film Festival taking place in Rome this week. The award is among the five most important of the festival, together with the Best Film, Best Director, Best Actress, and
-The national COVID-19 vaccine fund had received over 320 million USD as of Thursday. The fund’s management board has opened 21 accounts for donations made in VND and hard currencies at the State Treasury and several commercial banks. The use, management and opening of accounts at the State Treasury are publicised on the mass
The Pfizer-BioNTech vaccine is highly effective against the Delta variant of COVID-19, a Pfizer official in Israel said on Thursday. First identified in India, Delta is becoming the globally dominant version of the coronavirus, according to the World Health Organization. Alon Rappaport, Pfizer’s medical director in Israel, said data accumulating
